JSC Grindeks announced the company’s Supervisory Council has re-elected Juris Bundulis as its Chairman of the Board and elected Ph.D. Juris Hmelnickis in the Board...
Today, on 27 November, the JSC Grindeks submitted the non-audited consolidated financial statements for the first nine months of 2017 to “Nasdaq Riga”. Non-audited financial...
Grindeks and its subsidiary Kalceks announce, they will exhibit at the world’s largest pharma trade show CPhI Worldwide 2017 that will take place in Messe...
JSC Grindeks has received Russian Good Manufacturing Practice (GMP) certificate to confirm the quality system of Grindeks complies with the current legislative requirements in one...
Today, on 28 August, the JSC Grindeks submitted the non-audited consolidated financial statements for the first half-year of 2017 to “Nasdaq Riga”. Non-audited financial results...
Today, on 17 July, JSC Grindeks submitted to Nasdaq Riga the company’s Annual Report and the Corporate Social Responsibility Report for the year 2016, to...
